Welcome : Guest

Intrexon Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Intrexon Corporation, which is principally involved in the Manufacture of Biologically based Products. Illustrated with 102 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-64670
Price: $3500
Company Type: Public
Pages: 107
Date: November 2016
Market Data Tables: 102

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
DNA Carrier Testing......5
Table 1: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......5
DNA & Gene Chips (Microarray)......6
Table 2: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......6
Table 3: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......7
Table 4: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......8
Genetic Testing......9
Table 5: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......9
Table 6: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......10
Table 7: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......11
Genomic Technology......12
Table 8: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......12
Table 9: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......13
Table 10: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......14
Table 11: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......15
Table 12: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......16
Genomic Tools......17
Table 13: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......17
Genomics 2.0......18
Table 14: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......18
Table 15: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......19
Table 16: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......20
Table 17: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......21
Table 18: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......22
Table 19: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......23
Table 20: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......24
Table 21: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......25
Table 22: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......26
Table 23: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......27
Table 24: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......28
Table 25: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......29
Table 26: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......30
Table 27: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......31
Table 28: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......32
Oncology Genomics......33
Table 29: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......33
Table 30: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......34
Table 31: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......35
Protein Analysis......36
Table 32: Protein Analysis End Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Academic and Government, Applied, Industrial and Others, and Biotech, Pharma and CROs......36
Table 33: Protein Analysis Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Consumables, Services, and Instrumentation......37
Protein Microarray......38
Table 34: Protein Microarray Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Europe, North America, and Rest of World......38
Protein Separation Analysis......39
Table 35: Protein Separation Analysis Market by Configuration Worldwide (2015) - Percentage Share Breakdown by Value Sales for Capillary Electrophoresis (CE), Flash, Gas Chromatography (GC), High Performance Liquid Chromatography (HPLC)/Ultra Pure Liquid Chromatography (UPLC), Ion Chromatography (IC), Low Pressure Liquid Chromatography (LPLC), and Others......39
Cancer Drugs......40
Table 36: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......40
Table 37: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......41
Cancer Market......42
Table 38: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......42
Table 39: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......43
Table 40: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......44
Table 41: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......45
Table 42: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......46
Table 43: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......47
Table 44: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......48
Table 45: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......49
Cancer Patients......50
Table 46: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......50
Table 47: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......51
Table 48: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......52
Table 49: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......53
Table 50: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......54
Table 51: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......55
Table 52: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......56
Table 53: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......57
Table 54: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......58
Table 55: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......59
Table 56: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......60
Table 57: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......61
Table 58: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......62
Table 59: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......63
Table 60: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......64
Table 61: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......65
Table 62: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......66
Table 63: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......67
Table 64: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......68
Table 65: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......69
Table 66: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......70
Cervical Cancer......71
Table 67: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......71
Table 68: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......72
Hematological Cancer......73
Table 69: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......73
Skin Cancer......74
Table 70: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......74
Cancer-Associated Mucositis......75
Table 71: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......75
Chronic Myelogenous Leukemia (CML)......76
Table 72: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......76
Multiple Myeloma......77
Table 73: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......77
Table 74: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......78
Biologics......79
Table 75: Biologics Market by Component Worldwide (2015) - Percentage Share Breakdown by Value for Insulin, Multiple Sclerosis, Oncology, Tumor Necrosis Factor, and Others......79
Table 76: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......80
Table 77: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......81
Table 78: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, and Chemicals......82
Table 79: Therapeutic Biologics Market by Type in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......83
Table 80: Biologics Therapeutic Classes Market by Category in China (2015) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......84
Table 81: Dermatology Biologics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......85
Infectious Disease Drugs......86
Table 82: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......86
Table 83: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......87
Genomics 2.0......88
Table 84: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......88
Cancer Drugs......89
Table 85: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......89
Table 86: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......90
Table 87: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......91
Table 88: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......92
Table 89: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......93
Breast Cancer Drugs......94
Table 90: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......94
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......95
Table 91: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......95
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......96
Table 92: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......96
Table 93: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......97
Biologics......98
Table 94: Market Shares of Leading Biologics/Vaccines Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......98
Table 95: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......99
Table 96: Market Shares of Leading Biologic Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for AbbVie Inc., Amgen, Inc. and Pfizer, Inc., Johnson & Johnson, Roche Holding AG and Others......100
Infectious Disease Drugs......101
Table 97: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......101
Table 98: Intrexon Corporation's Sales by Segment in the US (2015) - Percentage Share Breakdown by Value for Product Revenues, Research and Development Services, Service Revenues, and Others......102
Table 99: Intrexon Corporation’s Exclusive Channel Collaboration (ECC) Cost Recovery Sales by Segment in the US (2015) - Percentage Share Breakdown by Value for Energy, Environmental, Food, and Health Care......103
Table 100: Intrexon Corporation’s Exclusive Channel Collaboration (ECC) Upfront Sales by Segment in the US (2015) - Percentage Share Breakdown by Value for Energy, Environmental, Food, and Health Care......104
Table 101: Intrexon Corporation’s Exclusive Channel Collaboration (ECC) Milestone Sales by Segment in the US (2015) - Percentage Share Breakdown by Value for Energy, Environmental, Food, and Health Care......105
Table 102: Intrexon Corporation’s Exclusive Channel Collaboration (ECC) Sales by Sector in the US (2015) - Percentage Share Breakdown by Value for Cost Recovery Revenues, and Upfront Revenues......106